Clinical Trials in Ellwangen, Germany
Locations / Ellwangen, Germany
Delta Trials records 48 clinical trials conducted in Ellwangen, Germany, making it a notable site of clinical research activity. These trials across 32 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 5 trials in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Ellwangen has changed over time.
48
Total Trials
32
Conditions
5
Terminated since 2020
Browse by condition (32 total)
- Alzheimer's disease 12 trialsAll Alzheimer's disease trials
- Major depressive disorder 4 trialsAll Major depressive disorder trials
- Schizophrenia 4 trialsAll Schizophrenia trials
- Restless legs syndrome 4 trialsAll Restless legs syndrome trials
- Depressive disorder, major 2 trialsAll Depressive disorder, major trials
- All Attention deficit hyperactivity disorder trials
- Severe chronic pain 2 trialsAll Severe chronic pain trials
- Lymphoma 2 trialsAll Lymphoma trials
- Bipolar disorder mania 1 trialAll Bipolar disorder mania trials
- Retention disorder, cognitive 1 trialAll Retention disorder, cognitive trials
- Anemia 1 trialAll Anemia trials
- Breast cancer 1 trialAll Breast cancer trials
- All Idiopathic restless legs syndrome trials
- Treatment resistant depression 1 trialAll Treatment resistant depression trials
- Non-erosive reflux disease 1 trialAll Non-erosive reflux disease trials
- Parkinson's disease 1 trialAll Parkinson's disease trials
- Cognitive impairment 1 trialAll Cognitive impairment trials
- All Erosive gastroesophageal reflux disease trials
- All Memory, concentration or attention problems trials
- All Moderate to severe plaque psoriasis trials